The effect of human fibrinogen on the proliferation of purified SBA-CD34+ human bone marrow progenitors was investigated in clonal cultures. Fibrinogen alone or in combination with erythropoietin had no significant effect. However, in the presence of recombinant human interleukin-3 (IL-3). fibrinogen increased significantly in a dose-dependent manner the number of mixed and burst-forming unitethrocyte-derived colonies, whereas the number of other colonies did not significantly change. In the presence of fibrinogen, low concentrations of IL-3 (0.1 7 U/mL) produced three times more mixed colonies than without fibrinogen, reaching the number of colonies obtained with optimal concentrations of IL-3 (1.67 U/mL). Fibrinogen fragment D had the same effect in the presence of IL-3 as intact fibrinogen, whereas fibrinogen fragment E and hu-ECENT PROGRESS in human hematopoietic pro-R genitor purification and culture, and in molecular gene cloning of peptidic growth factors has permitted analysis of the role of various interleukins and colony-stimulating factors (CSFs).' They have a short half-life and a low concentration; they are often produced in an autocrine or paracrine manner. They trigger specific high-affinity transmembrane receptors usually present in low number (50 to 5,000 per cell). Beside these high-affinity growth factors, some major components of the bone marrow environment may play an important role in the regulation of hematopoietic progenitor proliferation and differentiati~n.'?~ For instance, fibrinogen and fibronectin, which are present in the hematopoietic microenvironment, can modulate the effects of growth factors on human hemop~iesis.~. ' (RGD-peptides) , a , , , & (OKM-I), and ax& (HC1/1) did not affect the observed mitogenic effect. The mitogenic effect of fibrinogen and its D fragment was not mediated by induction of IL-6 or granulocyte-colony-stimulating factor secretion, because it was not inhibited by blocking antisera against these two growth factors. Our results indicate that fibrinogen potentiates the effect of IL-3 on primitive hematopoietic progenitors and suggest that the mitogenic effect of fibrinogen could be mediated via a specific mitogenic receptor that does not belong to the integrin family. been shown to promote cell proliferation of erythroid progenitor~~,~,' and colony-forming unit-spleen (CFU-S)-derived spleen colonies' via adhesion processes, whereas others, such as glycosaminoglycans, specifically retain and deliver growth factors, such as granulocyte macrophage-colony-stimulating factor, to hematopoietic progenitors."~' '
Human fibrinogen, a 340-Kd plasma protein also present in regenerating tissues and bone marrow, is known to be an adhesive protein responsible for platelet aggregation and endothelial cell adhesion. We have also shown that it is a mitogenic factor that increases the production of early progenitors in long-term Dexter human bone marrow cultures and the proliferation of T and B lymphoma-derived cell lines in serum-free culture conditiom6 However, in the Dextertype cultures, it was not possible to discriminate between a direct effect of fibrinogen on hematopoietic progenitors and an effect on the stroma-triggering secretion of hematopoietic growth factors.
In this study, we have further analyzed the mitogenic effect of human fibrinogen on highly purified SBA-CD34+ progenitors in clonal, low cell density methylcellulose cultures. We have found that fibrinogen potentiates the stimulating effect of low concentrations of recombinant human interleukin-3 (IL-3), which becomes as effective as much higher concentrations of IL-3 commonly used in cell cultures.
MATERIALS AND METHODS
One liter of fresh human blood from four healthy donors was collected directly on 100 mL of 3.8% (wt/vol) trisodium citrate buffer containing 2 mmol/L phenylmethane sulfonyl fluoride (PMSF), 2 mmol/L benzamidine, 10 mmol/L EDTA, 200 mmol/L e-aminocaproic acid, 0.2% NaN, (wt/vol), 100 U/mL aprotinin, and 0.5 U/mL hirudin. Blood was immediately cooled on ice, then centrifuged at 2,000g for 20 minutes at 4°C. Fibrinogen was purified from the resulting plasma according to Kekwick et al." All buffers were supplemented with 2 mmol/L PMSF, 100 U/mL aprotinin, and 0.5 U/mL hirudin. The fibronectin residue was removed from the fibrinogen preparation by affinity chromatography on gelatin-agarose13 and eluted by 50 mmol/L Tris-HCI, pH 7.5,4 mol/L urea buffer. The purified Preparation of human jibrinogen andjibronectin.
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For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From 80 1 fibronectin was dialyzed against 150 mmol/L NaC1, 10 mmol/L Na2HP04/KH2P04 buffer (PBS), pH 7.4, and frozen at -30°C. The fibrinogen and fibronectin preparations were more than 99% pure as assayed by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE).I4 The purified fibrinogen preparation can be stored for 1 year at -70°C without decrease ofits biological activity.
Preparation of fibrinogen fragments D and E. One hundred eighty milligrams of human fibrinogen were dialyzed against 150 mmol/L NaCI, 10 mmol/L Tris-HC1 buffer, pH 7.4. Fibrinogen was then hydrolyzed by 6.75 casein units of human plasmin (KabiVitrum, Stockholm, Sweden) in the presence of 20 U hirudin and 2.5 mmol/L CaCl, for 28 hours at 37°C. The extension of the proteolysis was followed by electrophoresis on a 7.5% polyacrylamide gel in nonreducing conditions.15 The reaction was stopped by 3,000 U aprotinin.
The resulting hydrolysate was dialyzed against IO mmol/L NaHCO3/Na2CO, buffer, pH 8.9. Fragments D and E were purified on diethyl aminoethyl (DEAE) cellulose according to Doolittle et a1.I6 The fragment D fraction was a mixture of fragments DI, D2, and D3 in 45%/45%/10% proportions. Fragment E fraction was contaminated by less than 1% fragment D as seen by SDS-PAGE.
Fibronectin-depleted fetal calf serum. Bovine fibronectin was removed from 100 mL of the serum batch used for cultures by affinity chromatography on gelatin-agarose as described above. The depletion of fibronectin was assessed by Western blot analysis. Briefly, purified fibronectin, complete serum, and fibronectin-depleted serum were submitted to electrophoresis on a 7.5% polyacrylamide gel in reducing conditions according to Laemm1i.l' The fibronectin band was revealed after electrical transfer on nitrocellulose by the following incubations: 1/200 dilution of goat antihuman fibronectin polyclonal antibody (Sigma Chemical CO, St Louis, MO) overnight at 4°C; then 1/500 dilution of peroxidase-conjugated rabbit anti-goat F(ab)', (Immunotech, Marseille, France) for I hour at 20°C. Each incubation was performed in PBS supplemented with 2% bovine serum albumin and 0.05% Tween-20, and followed by 4 washes in the same buffer without serum albumin. The peroxidase conjugates were revealed by incubation in 0. I mol/ L Tris-HC1 buffer, pH 7.8, supplemented with 0.5 mg/mLdiaminobenzidine and 0.006% H,Oz.
The GRGDS and RGES peptides. The pentapeptide Gly-ArgGly-Asp-Ser (GRGDS) (BACHEM Feinchemikalien AG, Bubendorf, Switzerland) and the tetrapeptide Arg-Gly-Glu-Ser (RGES) (Sigma Chemical CO) were diluted in Iscove's modified Dulbecco's medium (IMDM) (Biochrom, AngoulCme, France), then the pH was adjusted to 7.2 with a saturated NaHCO, solution. The inhibition of attachment of Normal Rat Kidney (NRK) cells by these peptides was tested according to Pierschbacher and Ru0s1ahti.l~ GRGDS inhibited the attachment of NRK cells to fibronectincoated surface in a dose-dependent manner, whereas RGES did not.
Recombinant human erythropoietin (Epo) was supplied by Boehringer (Mannheim, Germany). Recombinant human IL-3, IL-6, Granulocyte-CSF (G-CSF), antihuman IL-6 and antihuman G-CSF antisera were provided by Dr S.C. Clark from Genetics Institute (Cambridge, MA). Specific activities of these cytokines were respectively 7 X IO4 U/mg, 2.3 X IO6 U/mg, 4 X lo6 U/mg, and 7 X lo4 U/mg. For recombinant human IL-3, 1 U/mL is the dose necessary to obtain 50% of the maximal effect and the plateau is reached at 1.67 U/mL. Rabbit antihuman G-CSF at the dilution 1/250 neutralized a saturating dose of G-CSF. Goat antihuman IL-6 at the l/l,OOO dilution neutralized 5 U/mL IL-6.
Before their use in culture, OKM-I (Ortho Diagnostic Systems, Raritan, NJ), HC1/1 (a gift of Dr F. Sanchez-Madrid) MoAbs and
Hematopoieticgrowth factors and specific antibodies.
mouse IgGzb (Coulter Immunology, Hialeah, FL) were desalted on a G25 column equilibrated with PBS to remove sodium azide.
Bone marrow. Specimens of bone marrow from the iliac crest, ribs, or sternum were obtained from either normal bones at orthopedic surgery or normal bone marrow transplant donors with their informed consent and/or under a protocol approved by the Institution's human subjects review committee. All samples were collected in IMDM containing 10% fetal calf serum (FCS) (Biological Industries, Kibbutz Beth Haemek, Israel) and 250 U/mL preservative-free magnesium heparinate (Biosedra, Malakoff, France).
SBA-CD34' cell purification. Cells were purified by two different methods that gave the same results. In a first series of experiments, CD34+ cells were purified as previously described.'* Then, the purification of CD34+ cells was further performed according to Lebkowski et al.I9 Briefly, low-density bone marrow mononuclear cells (BMMC) were separated using a standard gradient sedimentation on Ficoll-Hypaque (Pharmacia, Uppsala, Sweden). The BMMC were then incubated for 1 hour in plastic tissue culture flasks at 37°C to remove the plastic adherent cells. The nonadherent BMMC were collected, centrifuged, and resuspended in Dulbecco's phosphate-buffered saline, which is calcium and magnesium free, containing 1 mmol/L EDTA (DPBSE) at a maximum of 2 X IO' cells in 4 mL. The cells were then loaded into soybean agglutinin (SBA) covalently coated T25 tissue culture devices (SBA CELLector; Applied Immune Sciences, Menlo Park, CA) for 1 hour at room temperature. The SBA nonadherent cells (SBA-) were collected, pooled, centrifuged, and resuspended in DPBSE containing 0.5% human Igs (Bio-Transfusion, Roissy, France) and incubated for 15 minutes at room temperature. These cells were then loaded into CD34 (ICH3) MoAb-coated T25 tissue culture flasks (CD34 CELLector) at a maximum of 1.5 x IO7 cells per flask, and incubated for 1 hour at room temperature. The nonadherent cells (CD34-) were removed and the flasks gently washed five times with DPBSE. Finally, the flasks were loaded with 10 mL IMDM containing 10% fetal bovine serum (FBS) and incubated for 2 hours in 5% CO, at 37°C. The adherent SBA-CD34' cells were then easily dislodged by quickly shaking the device. The released BMMC SBA-CD34' cells were then collected, pooled, and concentrated as desired for further processing.
Punty of the CD34+ population was assessed by flow cytometry by labeling the cells with the CD34 MoAb 8G12 (Becton-Dickinson, Mountain View, CA) using a standard procedure?0 In our series, 92% to 97% of the purified cells expressed CD34 and the viability was higher than 95%. To confirm the stromal cell depletion during the incubation with SBA," the initial BMMC and the CD34+ populations were analyzed by flow cytometry for the detection of endothelial cells. Cells were labeled by standard indirect technique" using the MoAbs anti-von Willebrand factor F8/86 (Dako, Glostrup, Denmark) and BNH9 (Immunotech). Three percent of BMMC were endothelial cells before SBA depletion, whereas none was detected after the SBA-CD34+ selection. Furthermore, we did not detect endothelial cells after 14 days of culture of this SBA-CD34' population whatever the conditions used.
Colony assay. The enriched population was plated at low cell density according to a modified procedure of the mixed colony assay of Messner et alZ2 in which IO4 cells were plated per 35-mm Petri dish in IMDM containing 0.9% (wt/vol) methylcellulose, IO pg/mL transferrin, 1 mg/mL deionized bovine serum albumin (BSA),23 30% complete FCS or 10% fibronectin-depleted FCS, I U/mL Epo, and specified concentrations of IL-3, fibrinogen or fibronectin. All experiments were performed in duplicate. Cultures were incubated in a 5% CO2 humidified atmosphere at 37°C. On the 14th day of incubation, all colonies of each dish were determined and counted in situ with a Diavert Leitz (Wetzlar, When cytologic confirmation was required, colonies were individually lifted from methylcellulose by a finely drawn Pasteur pipette. The smear obtained from each clone on a glass slide was stained with May-Griinwald Giemsa stain (Merck, Darmstadt, Germany).
Significant differences between treatment groups were determined by using Student's t-test analysis applied to paired samples. Probabilities from significance tests are detailed in Results.
Statistical evaluations.

RESULTS
Effect of fibrinogen on hematopoietic progenitors in the presence of IL-3 and Epo. Figure 1 shows the effect of fibrinogen on CD34' cell cultures in the presence of I U/ mL Epo and 0. I7 U/mL IL-3. Fibrinogen enhanced in a dose-dependent manner up to 3 times the number of mixed colonies (P < .OO 1, degrees of freedom [dfl = I 1). This effect was observed even with 10 pg/mL (P < .005, df = 7). The number of colonies derived from the burst-forming unitgranulocyte (BFU-E) were also increased ( P < .05,5 I df I 9), whereas the increase of colony-forming unit-granulocyte (CFU-G)-derived colonies was not significant (P = .2, 5 I df 5 9). No effect was observed for CFU-erythrocyte (E)-, CFU-granulocyte monocyte (GM)-, and CFU-monocyte (M)-derived colonies. Figure 2 shows the effect of fibrinogen on mixed colonies in the presence of Epo and various doses of IL-3. This effect is more obvious at low concentrations of IL-3. Indeed, with 0.17 U/mL or 0.33 U/mL IL-3, 60 &mL fibrinogen increased the mixed colony number up to 310% (P < .001, df = 5 ) or 180% (P < .O 1, df = 5), respectively. On the contrary, at a higher concentration of IL-3 ( I .67 U/mL), the number of mixed colonies was not increased even by 60 pg/mL fibrinogen. An optimal dose of fibrinogen (30 pg/mL or 60 &mL) in the presence of low concentrations of IL-3 (0.17 U/mL or 0.33 U/mL), produced a number of mixed colonies similar to that obtained with a higher, perhaps less physiologic concentration of IL-3 ( I .67 U/mL), with or without fibrinogen. In addition to the increase in the number of mixed and BFU-E-derived colonies, fibrinogen also increased the size of these colonies (not shown).
In contrast, fibrinogen alone or in combination with Epo but without IL-3 did not sustain the proliferation ofhematopoietic progenitors (data not shown), unless a stromal layer was added to the culture. 6 To distinguish intrinsic mitogenic activity of fibrinogen from proliferation caused by cell-cell or cell-substratum adhesion, we assayed in these culture conditions fibrinogen fragments D and E which are both unable to polymerize in fibrin and form a three-dimensional matrix.28 Figure 3 shows that in the presence of IL-3, fibrinogen fragment D increased the number of mixed colonies similarly to the intact fibrinogen molecule (P < .005, df = 3). On the contrary, fibrinogen fragment E and human collagen IV, an unrelated adhesive protein of basement membranes, did not alter the number of mixed colonies obtained in the presence of IL-3.
We wanted further to exclude the possibility that this mitogenic effect was mediated by integrins that are able to bind fibrinogen such as the glycoprotein complex IIb -IIIa (a,,,p3) , the vitronectin receptor (a,P3), Mac-1 (amp2), and pl50,95 (a,&) . ' For this purpose, we assayed in our culture system the GRGDS peptide that inhibits fibrinogen binding on nectin-depleted serum as described in Materials and Methods to avoid an inhibiting effect of peptides on the fibronectin present in the crude serum. Figure 4A shows that 0.5 mmol/L GRGDS was unable to inhibit the effect of 29 nmol/L fibrinogen on mixed, BFU-E-and CFU-G-derived colonies grown in the presence of IL-3. The inactive control peptide RGES had no effect. In the same culture conditions, fibronectin in combination with IL-3 significantly increased the growth of BFU-E-, CFU-E-, and CFU-M-derived colonies. By contrast with what we observed with fibrinogen, Fig. 4B shows that the effect of 29 nmol/L exogeneous fibronectin on the growth of BFU-E (P < .05, df = 3), CFU-E (P < . l), and CFU-M (P -= .05) was inhibited by the addition of 0.5 mmol/L GRGDS peptide. On the other hand, neither OKM-1 nor HC1/1 MoAbs altered the effect of fibrinogen on mixed and BFU-E-derived colonies (Table 1 ).
Effect offibrinogen fragments D and E.
Efect of fibrinogen is not mediated by integrins.
An efect independent from induction of IL-6 or granulocyte (G)-CSF secretion.
We have confirmed the observation that IL-6 and G-CSF potentiate the mitogenic effect of IL-3 on CFU-granulocyte, erythroid, monocyte, megakaryocyte (GEMM).32, 33 The effect of IL-6 added to IL-3 was similar to that observed when we added fibrinogen to IL-3. To investigate the possibility that fibrinogen could induce a paracrine or an autocrine secretion of IL-6 or granulocyte (G)-CSF, we assayed the effect of anti-IL-6-and anti-G-CSF-blocking antisera in our culture system. As shown in Fig 5, a dose ofantiserum able to block the effect of a saturating dose of G-CSF was unable to inhibit the effect of 30 pg/mL fibrinogen or its D fragment on mixed colonies. Similarly, a dose of antiserum able to inhibit half of the effect induced by 5 U/mL IL-6 was unable to inhibit the effect of fibrinogen and its D fragment on mixed colonies. These results clearly show that the potentiating effect of fibrinogen and its D fragment on growth of earlier progenitors in the presence of IL-3 is independent from the induction of IL-6 or G-CSF secretion.
DISCUSSION
We have previously shown that fibrinogen has a mitogenic effect on established hematopoietic cell lines in serum-free liquid culture. Moreover, we have demonstrated that fibrinogen was able to double the time during which early human bone marrow progenitors were produced to maintain an active long-term bone marrow culture. 6 In those experiments, low concentrations (3 to 10 &mL) of highly purified fibrinogen were added to human Dextertype cultures with serum batches containing less than 1 pg/ mL of fibrin(ogen) proteolytic fragments. However, a direct effect of fibrinogen on the proliferation of purified early human hematopoietic progenitors in semisolid culture conditions has not yet been demonstrated. In this series we have studied the cooperative effect of fibrinogen with Epo and Proteins, pg/ml 1L-3 on a purified SBA-CD34+ cell population in semisolid methylcellulose culture. Our results show that fibrinogen alone or in the presence of Epo has no significant effect on the colony formation of SBA-CD34+-enriched progenitors. However, in the presence of very low concentrations of IL-3 (0. I7 or 0.33 U/mL), fibrinogen markedly increased in a dose-dependent manner the number of CFU-GEMM-and large BFU-E-derived colonies. Both size and number ofcolonies were similar to those observed using I .67 U/mL IL-3, a dose sufficient to obtain the maximal effect of IL-3 in our culture conditions. No effect was seen on CFU-E-, CFU-GM-, and CFU-M-derived colonies. It is unlikely that this effect is triggered by integrins as observed with fibronecIndeed, OKM-I and HCI/l monoclonal antibodies, which inhibit fibrinogen binding on cu,P,/Mac-1 30 and cu,&/pl 50,9531 integrins, and RGD-containing peptides such as GRGDS and GRGDSP, which inhibit fibrinogenand fibronectin-mediated cell adhesion processes via CY,&,/ gplIblIIa and a,P3 integrin~,'~ did not alter the mitogenic effect of fibrinogen and its D fragment. In contrast, RGDcontaining peptides inhibited the effect of fibronectin on the growth of BFU-E-, CFU-E-, and CFU-M-derived colonies as previously described by Weinstein et al.' Furthermore, fibrinogen fragment D, which is unable to polymerize in a three-dimensional matrix and to induce cell adhesion via integrin~.~".'~ still retains the mitogenic effect of the intact fibrinogen molecule, whereas fibrinogen fragment E does not. The possibility that the mitogenic effect of fibrinogen on SBA-CD34' cells may be caused by some structural modification or presentation of IL-3 resulting from its association with fibrinogen that would improve IL-3 activity is unlikely. Indeed, the mitogenic effect of fibrinogen is not observed on all cell types that respond to IL-3, but mainly on the most immature ones.
We have confirmed what was observed by other investig a t o r~~' .~~ that IL-6 or G-CSF in the presence of IL-3 increased significantly the number of mixed colonies. It has I I I a ? .
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IL3+ Fg 11.3 + FD IL3+11.6 IL3c (;-CSF Effect on mixed colony growth of antihuman IL-6 and antihuman G-CSF antisera. CD34+ cells were plated at 4 X lo3 cells/mL in the absence of antiserum (open columns), or in the presence of a dose of antihuman IL-6 antiserum able to inhibit half the effect induced by 5 U/mL 11-6 (hatched columns) or antihuman G-CSF (solid columns) able to inhibit a saturating dose of G-CSF. Concentrations of Epo, IL-3, fibrinogen, its D fragment (Fd), IL-6, and G-CSF were, respectively, 1 U/mL, 0.1 6 U/mL, 30 pg/mL, 3 0 pg/ mL, 5 U/mL, and 3.3 U/mL. ND, not determined. For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From been shown that IL-6 and G-CSF play an important role in triggering quiescent stem cells to proliferate." Therefore, we checked whether fibrinogen might induce the secretion of IL-6 or G-CSF. Indeed, fibrinogen fragment D is able to bind to macrophages and monocyte^'^.^' and to promote IL-6 synthesis on a macrophage cell line." Our present results invalidate the possibility of an induction of paracrine or extracellular autocrine loops for these growth factors, because neither antihuman G-CSF nor antihuman IL-6 antisera were able to inhibit the potentiating effect of fibrinogen and its D fragment on mixed colony proliferation in the presence of IL-3. However, this does not exclude the possibility of an induction of an intracellular autocrine loop.
Another possible mechanism could be a direct interaction of fibrinogen with stromal cells, inducing a secretion of the Steel factor (SF). This hypothesis is unlikely for at least three reasons. First, fibrinogen has no effect in combination with Epo without IL-3, whereas SF in these conditions strongly enhances growth of BFU-E and CFU-E.39 Second, after cell purification in our culture system, we have never detected by flow cytometry at either the beginning or the end of the culture period any stromal or endothelial cell that could indeed secrete SF.40 Third, these SBA-CD34+ cells from adult bone marrow could never establish a stromal layer in our culture conditions during the time course of experiments.
One possible mechanism could be that fibrinogen upregulates receptors for IL-3 or other growth factors, thereby increasing colony formation by CFU-GEMM and BFU-E. Although it remains to be demonstrated, this mechanism could be triggered by the mitogenic fibrinogen receptor that we identified on lymphoid cell lines Raji and J~r k a t .~~ Indeed, the specificity of this receptor for different fibrinogen fragments is well correlated with the ability of these fragments to cooperate with IL-3 to stimulate immature progenitors.
In conclusion, our work points out that extracellular matrix (ECM) and major plasma proteins are important co-mitogens of the hematopoietic system. These ECM proteins were first described as localizing progenitors in the bone marrow by cytoadhesive p r o c e~s e s~~~ and storing some growth factors." They were more recently found to be involved in the stimulation of cell growth. For instance, the interaction of fibronectin with cellular integrins very late antigen (VLA)-4 was shown to be involved in the development of murine colony-forming unit-spleen (CFU-s) colonies: thrombospondin to increase the proliferation of immature progenitors triggered by SF.44 However, in all these cases, ECM proteins act via cytoadhesive processes, whereas fibrinogen seems to stimulate IL-3-dependent growth of immature progenitors independently of cytoadhesion. Finally, the comitogenic action of ECM proteins could be a general phenomenon allowing cytokines to act at much lower concentrations, decreasing the downregulation ofcytokine receptor^.^',^^ Moreover, the fact that some high-affinity growth factors, such as CSF-1 : ' transforming growth factor 01,"' and SF,44 can remain linked to the cell membrane, to promote cell attachment to a cell expressing the corresponding receptor, and cell proliferation is another example of possible relationships between cell attachment, proliferation, ECM proteins, and growth factors.
